Avecho Biotechnology Limited (AVEFF)
OTCMKTS · Delayed Price · Currency is USD
0.0045
-0.0129 (-74.14%)
At close: May 2, 2025
Avecho Biotechnology Market Cap
Avecho Biotechnology has a market cap or net worth of $26.06 million as of February 12, 2026. Its market cap has increased by 341.01% in one year.
Market Cap
26.06M
Enterprise Value
21.89M
Revenue
905.10K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 28, 1996, Avecho Biotechnology's market cap has decreased from 30.06M to 26.06M, a decrease of -13.31%. That is a compound annual growth rate of -0.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 26.06M | 18.16% |
| Dec 31, 2025 | 22.05M | 349.75% |
| Dec 31, 2024 | 4.90M | -35.15% |
| Dec 29, 2023 | 7.56M | -59.65% |
| Dec 30, 2022 | 18.74M | -6.27% |
| Dec 30, 2021 | 19.99M | -44.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vicapsys Life Sciences | 48.56M |
| Arch Biopartners | 43.72M |
| ZIVO Bioscience | 40.17M |
| Cell Source | 38.23M |
| Harvard Apparatus Regenerative Technology | 31.12M |
| Oncotelic Therapeutics | 27.82M |
| EOM Pharmaceuticals Holdings | 22.63M |
| Finch Therapeutics Group | 22.08M |